assumes that your firm is considering accepting NewSkin Pharma as a new audit client. NewSkin is a start-up biotech firm that has publicly traded stock on NASDAQ. Your audit partner has asked you to perform some preliminary work for the firms client acceptance process. Required: a. Prepared a list of business risks hat NewSkin likely will face as a start-up biotech firm. b. Choose two of these risks and consider how they might affect your decision to accept NewSkin as a client